BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19150783)

  • 1. Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype.
    Cao M; Liang Y; Shen C; Miller KD; Stantz KM
    IEEE Trans Med Imaging; 2009 Jun; 28(6):861-71. PubMed ID: 19150783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on "Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype".
    Abramyuk A; Wolf G; Hietschold V; Haberland U; van den Hoff J; Abolmaali N
    IEEE Trans Med Imaging; 2010 Apr; 29(4):1088-9; author reply 1089-92. PubMed ID: 20659827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the longitudinal intra-tumor physiological impulse response to VEGFR2 blockade in breast tumors using DCE-CT.
    Stantz KM; Cao M; Cao N; Liang Y; Miller KD
    Mol Imaging Biol; 2011 Dec; 13(6):1183-95. PubMed ID: 20957443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Tumor-associated Stroma and Its Relationship with Tumor Hypoxia Using Dynamic Contrast-enhanced CT and (18)F Misonidazole PET in Murine Tumor Models.
    Koyasu S; Tsuji Y; Harada H; Nakamoto Y; Nobashi T; Kimura H; Sano K; Koizumi K; Hamaji M; Togashi K
    Radiology; 2016 Mar; 278(3):734-41. PubMed ID: 26393963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of guided random sampling of TCCs on blood flow values in CT perfusion studies of lung tumors.
    Gibaldi A; Barone D; Gavelli G; Malavasi S; Bevilacqua A
    Acad Radiol; 2015 Jan; 22(1):58-69. PubMed ID: 25481516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
    Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation and segmentation of cerebral tumors by mapping blood-brain barrier disruption with dynamic contrast-enhanced CT and tracer kinetics modeling-a feasibility study.
    Bisdas S; Yang X; Lim CC; Vogl TJ; Koh TS
    Eur Radiol; 2008 Jan; 18(1):143-51. PubMed ID: 17701183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physiologic imaging pilot study of breast cancer treated with AZD2171.
    Miller KD; Miller M; Mehrotra S; Agarwal B; Mock BH; Zheng QH; Badve S; Hutchins GD; Sledge GW
    Clin Cancer Res; 2006 Jan; 12(1):281-8. PubMed ID: 16397053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis?
    Goh V; Halligan S; Daley F; Wellsted DM; Guenther T; Bartram CI
    Radiology; 2008 Nov; 249(2):510-7. PubMed ID: 18812560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced CT of head and neck tumors: comparison of first-pass and permeability perfusion measurements using two different commercially available tracer kinetics models.
    Bisdas S; Konstantinou G; Surlan-Popovic K; Khoshneviszadeh A; Baghi M; Vogl TJ; Koh TS; Mack MG
    Acad Radiol; 2008 Dec; 15(12):1580-9. PubMed ID: 19000875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
    Kierkels RG; Backes WH; Janssen MH; Buijsen J; Beets-Tan RG; Lambin P; Lammering G; Oellers MC; Aerts HJ
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):400-8. PubMed ID: 19733445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the zonal organization of tumor perfusion and permeability in a rat glioma model by using dynamic contrast-enhanced synchrotron radiation CT.
    Balvay D; Troprès I; Billet R; Joubert A; Péoc'h M; Cuenod CA; Le Duc G
    Radiology; 2009 Mar; 250(3):692-702. PubMed ID: 19095783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.
    Li KL; Wilmes LJ; Henry RG; Pallavicini MG; Park JW; Hu-Lowe DD; McShane TM; Shalinsky DR; Fu YJ; Brasch RC; Hylton NM
    J Magn Reson Imaging; 2005 Oct; 22(4):511-9. PubMed ID: 16161072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.
    Kim TH; Yoon JK; Kang DK; Lee SJ; Jung YS; Yim H; An YS
    Ann Surg Oncol; 2015 Nov; 22(12):3866-72. PubMed ID: 25805237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis.
    Bisdas S; Konstantinou GN; Lee PS; Thng CH; Wagenblast J; Baghi M; Koh TS
    Phys Med Biol; 2007 Oct; 52(20):6181-96. PubMed ID: 17921579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
    Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
    Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.